A long-acting interleukin-7, rhIL-7-hyFc, enhances CAR T cell expansion, persistence, and anti-tumor activityMiriam Kim, John F. DiPersio|Nature Communications|2022Cited by 95
CD7-deleted hematopoietic stem cells can restore immunity after CAR T cell therapyMiriam Kim, John F. DiPersio|JCI Insight|2021Cited by 40